Sandy Spring Bank Intercept Pharmaceuticals, Inc. Transaction History

Sandy Spring Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$15.46 - $24.5 $3,092 - $4,900	-200 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$77.77 - $120.68 $7,777 - $12,068	-100 Reduced 33.33%	200 $16,000
Q1 2019 May 06, 2019	BUY	$91.83 - $120.68 $9,183 - $12,068	100 Added 50.0%	300 $34,000
Q4 2017 Feb 02, 2018	BUY	$58.2 - $72.76 $5,820 - $7,276	100 Added 100.0%	200 $12,000
Q3 2017 Nov 03, 2017	BUY	$57.01 - $118.75 $5,701 - $11,875	100	100 $6,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.